Oncology Programs at the FDA

Time spent developing novel cancer therapies is frequently measured in decisions as much as duration–each decision may speed a promising therapy to patients or lead to delay. For sponsors, understanding the full scope of programs offered by the FDA to speed up the approval of cancer treatments is critical.  

To learn more about key decision points at each stage of development, please see our recent blogs and webinar which provide a review of these programs: how to apply for them, how to apply them to drug development challenges, and their consequences for the future of oncology approvals.